COMPARISON OF LIPID LOWERING EFFECTS OF ROSUVASTATIN AND ATORVASTATIN IN TYPE 2 DIABETIC PATIENTS WITH PRIMARY HYPERLIPIDEMIA

Objective: To evaluate & compare the mean change in fasting serum total cholesterol and LDL-C levels from baseline, after 12 weeks of oral treatment with oral Rosuvastatin and with Atorvastatin in type 2 diabetic patients with primary hyperlipidemia. Study Design: Cross sectional comparative...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Safina Shabbir, Zill -e- Humayun, Muhammad Javad Yousaf, Muhammad Adnan Manzar, Shabana Mushtaq, Maria Yousaf
Formato: article
Lenguaje:EN
Publicado: Army Medical College Rawalpindi 2020
Materias:
R
Acceso en línea:https://doaj.org/article/d8f0d65f3f354ee8a7f84f9724a06ee8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!